Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT02188186
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT02188186
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02188186. Randomized; triple masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2018-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Initial triple combination
- Intervention (Drug)
- Conventional treatment
- Lead sponsor
- Seoul National University Bundang Hospital
Record details
- Record id
cardio:ct-nct02188186- Content hash
8f1a9879953393f075fcad8f6a8f1255f60d2dc4f1c6f4c8d33444bf7fcba83d